|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2005-1-4
|
|
pubmed:abstractText |
Methylxanthines and doxapram are currently used to treat apnea of prematurity but are not fully effective and often present undesirable side effects. The present study examines whether exposure to an odor known to modulate the infant's respiratory rate could reduce the frequency of apneic spells.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1098-4275
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
115
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
83-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15629985-Apnea,
pubmed-meshheading:15629985-Aromatherapy,
pubmed-meshheading:15629985-Bradycardia,
pubmed-meshheading:15629985-Caffeine,
pubmed-meshheading:15629985-Central Nervous System Stimulants,
pubmed-meshheading:15629985-Combined Modality Therapy,
pubmed-meshheading:15629985-Doxapram,
pubmed-meshheading:15629985-Drug Therapy, Combination,
pubmed-meshheading:15629985-Humans,
pubmed-meshheading:15629985-Infant, Newborn,
pubmed-meshheading:15629985-Infant, Premature,
pubmed-meshheading:15629985-Infant, Premature, Diseases,
pubmed-meshheading:15629985-Odors,
pubmed-meshheading:15629985-Physical Stimulation,
pubmed-meshheading:15629985-Respiratory System Agents,
pubmed-meshheading:15629985-Smell
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Olfactory stimulation prevents apnea in premature newborns.
|
|
pubmed:affiliation |
Centre National de la Recherche Scientifique, UMR 5170, site of Strasbourg, France. marlier@cesg.cnrs.fr <marlier@cesg.cnrs.fr>
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
